Angelo Marzano to Italy
This is a "connection" page, showing publications Angelo Marzano has written about Italy.
Connection Strength
0.155
-
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. J Am Acad Dermatol. 2021 05; 84(5):1356-1363.
Score: 0.039
-
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic. J Am Acad Dermatol. 2020 09; 83(3):965-969.
Score: 0.037
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021 06; 76(6):1813-1824.
Score: 0.010
-
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study. Expert Opin Biol Ther. 2021 02; 21(2):271-277.
Score: 0.010
-
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. J Allergy Clin Immunol. 2021 Feb; 147(2):558-560.e1.
Score: 0.010
-
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy. J Eur Acad Dermatol Venereol. 2020 Dec; 34(12):e770-e772.
Score: 0.009
-
What is the role of a dermatologist in the battle against COVID-19? The experience from a hospital on the frontline in Milan. Int J Dermatol. 2020 Jul; 59(7):e238-e239.
Score: 0.009
-
Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol. 2019 Apr; 33(4):742-752.
Score: 0.008
-
Italian Guidelines in Pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV). G Ital Dermatol Venereol. 2018 Oct; 153(5):599-608.
Score: 0.008
-
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines. G Ital Dermatol Venereol. 2018 Jun; 153(3):305-315.
Score: 0.008
-
Critical appraisal of the unmet needs in the treatment of chronic spontaneous urticaria with omalizumab: an Italian perspective. Curr Opin Allergy Clin Immunol. 2017 Dec; 17(6):453-459.
Score: 0.008